Seeing Is Believing
Healthcare - Sector
with an average price target of $22.21. This is a potential upside of $18.84 (559.05%) from yesterday's end of day stock price of $3.37.
Acasti Pharma's activity chart (see below) currently has 12 price targets and 18 ratings on display.
Analysts average stock forecasts to be materialized ratio is 30% with an average time for these price targets to be met of 32.8 days.
Most recent stock forecast was given by OREN LIVNAT from on 26-Sep-2024. First documented stock forecast 09-Jul-2019.
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 12-Jul-2023
$12
$8.63 (256.08%)
$12
1 years 3 months 29 days ago
(26-Sep-2024)
0/2 (0%)
$8.93 (290.88%)
Buy
$2.5
$-0.28 (-10.07%)
2 years 11 months 9 days ago
(15-Feb-2023)
1/1 (100%)
$1.86 (290.63%)
145
Buy
Since 22-Dec-2021
$30
3 years 7 months 2 days ago
(22-Jun-2022)
0/2 (0%)
$22.32 (290.63%)
Hold
Since 02-Sep-2020
$12
$8.63 (256.08%)
5 years 4 months 22 days ago
(02-Sep-2020)
1/2 (50%)
$1.58 (15.16%)
19
Buy
Since 31-Aug-2020
5 years 4 months 24 days ago
(31-Aug-2020)
0/1 (0%)
$59.52 (163.16%)
What is ACST (Acasti Pharma) average time for price targets to be met?
Which analyst has the current highest performing score on ACST (Acasti Pharma) with a proven track record?
Which analyst has the current lower performing score on ACST (Acasti Pharma) with a proven track record?
Which analyst has the most public recommendations on ACST (Acasti Pharma)?
Which analyst is the currently most bullish on ACST (Acasti Pharma)?
Which analyst is the currently most reserved on ACST (Acasti Pharma)?